Randomized Trial of Continuous Subcutaneous Delivery of Exenatide by ITCA 650 Versus Twice-Daily Exenatide Injections in Metformin-Treated Type 2 Diabetes

Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology Consensus Panel on Type 2 Diabetes Mellitus: An Algorithm for Glycemic Control

(2013) Helena Rodbard et al.   Endocrine Practice

Barriers to effective insulin treatment: the persistence of poor glycemic control in type 2 diabetes

(2011) Stuart A. Ross et al.   CURRENT MEDICAL RESEARCH AND OPINION

Standards of Medical Care in Diabetes--2012

(2011)   DIABETES CARE

Patient adherence to medication requirements for therapy of type 2 diabetes

(2011) C. J. Bailey et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

DURATION-5: Exenatide Once Weekly Resulted in Greater Improvements in Glycemic Control Compared with Exenatide Twice Daily in Patients with Type 2 Diabetes

(2011) Thomas Blevins et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Exenatide once weekly treatment maintained improvements in glycemic control and weight loss over 2 years

(2011) Kristin Taylor et al.   BMC Endocrine Disorders

Correlates of Insulin Injection Omission

(2010) M. Peyrot et al.   DIABETES CARE

A Meta-Analysis of Placebo-Controlled Clinical Trials Assessing the Efficacy and Safety of Incretin-Based Medications in Patients with Type 2 Diabetes

(2010) Walid K.H. Fakhoury et al.   PHARMACOLOGY

Glucagon-like peptide analogues for type 2 diabetes mellitus: systematic review and meta-analysis

(2010) Deepson S Shyangdan et al.   BMC Endocrine Disorders

Persistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organization

(2009) Catherine E. Cooke et al.   CURRENT MEDICAL RESEARCH AND OPINION

Patient characteristics, drug adherence patterns, and hypoglycemia costs for patients with type 2 diabetes mellitus newly initiated on exenatide or insulin glargine

(2009) Rosalind Fabunmi et al.   CURRENT MEDICAL RESEARCH AND OPINION

Barriers to Insulin Injection Therapy

(2009) Richard R. Rubin et al.   DIABETES EDUCATOR

Glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized clinical trials

(2009) Matteo Monami et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) Study

(2008) F. Álvarez Guisasola et al.   DIABETES OBESITY & METABOLISM

Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study

(2008) Daniel J Drucker et al.   LANCET